BIOMAT Database Logo BIOMAT Database Logo

Reporting of Azithromycin Activity against Clinical Isolates of Extensively Drug-Resistant Salmonella enterica Serovar Typhi. 2023

Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
University of Health Sciences, Lahore, Pakistan.

This study aimed to evaluate the minimum inhibitory concentration (MIC) of azithromycin (AZM) in clinical isolates of extensively drug-resistant (XDR) Salmonella Typhi (i.e., resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole, fluoroquinolones, and third-generation cephalosporin) using the E-test versus the broth microdilution method (BMD). From January to June 2021, a retrospective cross-sectional study was carried out in Lahore, Pakistan. Antimicrobial susceptibility was performed initially by the Kirby-Bauer disk diffusion method for 150 XDR Salmonella enterica serovar Typhi isolates, and MICs of all the recommended antibiotics were determined by the VITEK 2 (BioMérieux) fully automated system using Clinical Laboratory Standard Institute (CLSI) 2021 guidelines. The E-test method was used to determine AZM MICs. These MICs were compared with the BMD, which is the method recommended by the CLSI but not adopted in routine laboratory reporting. Of 150 isolates, 10 (6.6%) were resistant by disk diffusion. Eight (5.3%) of these had high MICs against AZM by the E-test. Only three isolates (2%) were resistant by E-test, having an MIC of 32 μg/mL. All eight isolates had a high MIC by BMD with different MIC distributions, but only one was resistant, having an MIC of 32 μg/mL by BMD. The sensitivity, specificity, negative predictive value, positive predictive value, and diagnostic accuracy of the E-test method versus BMD were 98.65%,100%, 99.3%, 33.3%, and 98.6%, respectively. Similarly, the concordance rate was 98.6%, negative percent agreement was 100%, and positive percent agreement was 33%. The BMD is the most reliable approach for reporting AZM sensitivity in XDR S. Typhi compared with the E-test and disk diffusion methods. Potentially, AZM resistance in XDR S. Typhi is around the corner. Sensitivity patterns should be reported with MIC values, and if possible, higher values should be screened for the presence of any potential resistance genes. Antibiotic stewardship should be strictly implemented.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012485 Salmonella typhi A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER. Salmonella enterica serovar Typhi,Salmonella typhosa
D014435 Typhoid Fever An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA. Enteric Fever,Typhus, Abdominal,Salmonella typhi Infection,Typhoid,Abdominal Typhus,Enteric Fevers,Fever, Enteric,Fever, Typhoid,Fevers, Enteric,Fevers, Typhoid,Infection, Salmonella typhi,Infections, Salmonella typhi,Salmonella typhi Infections,Typhoid Fevers,Typhoids
D017963 Azithromycin A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. Azadose,Azithromycin Dihydrate,Azithromycin Monohydrate,Azitrocin,Azythromycin,CP-62993,Goxal,Sumamed,Toraseptol,Ultreon,Vinzam,Zentavion,Zithromax,Zitromax,CP 62993,CP62993,Dihydrate, Azithromycin,Monohydrate, Azithromycin
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Rapid detection of ceftriaxone resistance in clinical isolates of extensively drug resistant Salmonella enterica serovar Typhi.
June 2021, JPMA. The Journal of the Pakistan Medical Association,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Superficial Thrombophlebitis caused by Extensively Drug-resistant Salmonella Enterica Serovar Typhi.
November 2020, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Whole-genome sequencing of extensively drug-resistant Salmonella enterica serovar Typhi clinical isolates from the Peshawar region of Pakistan.
February 2024, Journal of infection and public health,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
April 2020, Antimicrobial agents and chemotherapy,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Azithromycin-Resistant Salmonella enterica Serovar Typhi AcrB-R717Q/L, Singapore.
February 2021, Emerging infectious diseases,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Emergence of Novel Mutations in Extensively Drug-Resistant Salmonella enterica Serovar Typhi from Pakistan.
July 2020, Antimicrobial agents and chemotherapy,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Antibacterial efficacy of indigenous Pakistani honey against extensively drug-resistant clinical isolates of Salmonella enterica serovar Typhi: an alternative option to combat antimicrobial resistance.
February 2023, BMC complementary medicine and therapies,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Multidrug resistant Salmonella enterica serovar typhi.
January 2009, JNMA; journal of the Nepal Medical Association,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
Complete Genome Sequence of Salmonella Phage vB_SenA_SM5, Active against Multidrug-Resistant Salmonella enterica Serovar Typhi Isolates.
July 2022, Microbiology resource announcements,
Kokab Jabeen, and Sidrah Saleem, and Summiya Nizamuddin, and Faiqa Arshad, and Shah Jahan, and Faisal Hasnain, and Waleed Tariq, and Muhammad Junaid Tahir, and Zohaib Yousaf, and Muhammad Sohaib Asghar
First Case of Typhoid Fever due to Extensively Drug-resistant Salmonella enterica serovar Typhi in Italy.
February 2020, Pathogens (Basel, Switzerland),
Copied contents to your clipboard!